| 000 | 01620 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514040303.0 | ||
| 264 | 0 | _c20020917 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0004-8380 | ||
| 024 | 7 |
_a10.1046/j.1440-0960.2002.00600.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharkey, Michael P | |
| 245 | 0 | 0 |
_aLocalized cutaneous necrosis associated with the antiphospholipid syndrome. _h[electronic resource] |
| 260 |
_bThe Australasian journal of dermatology _cAug 2002 |
||
| 300 |
_a218-20 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Antiphospholipid _xanalysis |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiphospholipid Syndrome _xcomplications |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aNeck |
| 650 | 0 | 4 | _aNecrosis |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSkin Diseases _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
| 700 | 1 | _aDaryanani, Indiver I | |
| 700 | 1 | _aGillett, Martin B | |
| 700 | 1 | _aJones, Stephen K | |
| 773 | 0 |
_tThe Australasian journal of dermatology _gvol. 43 _gno. 3 _gp. 218-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1440-0960.2002.00600.x _zAvailable from publisher's website |
| 999 |
_c12012342 _d12012342 |
||